Ekaterina V. Glushkova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ekaterina V. Glushkova has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Nikolay I. Briko
I.M. Sechenov First Moscow State Medical University (Sechenov University)
8 shared publications - Nikita V. Nikitin
Sechenov University
4 shared publications - Alexey Yu. Brazhnikov
Sechenov University
2 shared publications - Anatoliy A. Korsunskiy
Federal State Autonomous Educational Institution of Higher Education I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
2 shared publications - Roman V. Polibin
Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Vladimir A. Korshunov
Sechenov University
2 shared publications
Latest Publications
- Open Access
- 30 August 2026
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 103 (4) , 484-494
Molecular genetic characterization of Streptococcus pyogenes isolates from pediatric patients in multidisciplinary hospitals in Moscow
Background. Streptococcus pyogenes (group A streptococcus, GAS) is a significant human bacterial pathogen causing a wide range of diseases, from upper respiratory tract infections to severe invasive forms. The increase in incidence in the post-COVID-19 period and the spread of hypervirulent clonal lineages, including M1UK (emm1 genotype), highlight the need for molecular genetic surveillance. Aim. To characterize the clonal structure, virulome and resistome of S. pyogenes strains isolated from hospitalized children and to assess their phenotypic antimicrobial susceptibility. Materials and methods. A total of 67 S. pyogenes strains isolated in 2023–2024 from hospitalized patients aged 0–17 years were studied. Identification was performed by MALDI-TOF mass spectrometry. Antimicrobial susceptibility testing was carried out by serial dilution methods. Whole-genome sequencing, genome assembly were performed. Bioinformatic analysis included emm typing, multilocus sequence typing, detection of virulence and antimicrobial resistance genes, and phylogenetic analysis. Results. Fourteen emm types and 19 sequence types were identified. The predominant clonal lineages were emm6/ST382 (16.4%), emm2/ST55 (14.9%), emm3/ST15 and emm75/ST49 (10.4% each). A strong association between emm and sequence types was observed (p 0.001; Cramer's V = 1.0). One strain of the M1UK lineage was identified among emm1/ST28 isolates. The virulence genes sagA, slo, mf/spd and speB were detected in all strains, while hylP was found in 86.6%. Among superantigen genes, speG (89.6%) and speC (68.7%) were most frequent. All strains were susceptible to β-lactams, clindamycin, linezolid, vancomycin. Resistance to erythromycin and tetracycline was detected in 4.5% and 14.9% of strains, respectively, and was predominantly associated with the mef(A)/msr(D) and tetM genes. Conclusion. S. pyogenes strains isolated from hospitalized children are characterized by genetic heterogeneity, a pronounced clonal structure, and genotype-specific distribution of superantigen genes. The results confirm the importance of whole-genome sequencing for monitoring the clonal structure, virulome and resistome of S. pyogenes within molecular epidemiological surveillance of GAS infections.
- 30 August 2026
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 103 (4) , 484-494
Open AccessMolecular genetic characterization of Streptococcus pyogenes isolates from pediatric patients in multidisciplinary hospitals in Moscow
Background. Streptococcus pyogenes (group A streptococcus, GAS) is a significant human bacterial pathogen causing a wide range of diseases, from upper respiratory tract infections to severe invasive forms. The increase in incidence in the post-COVID-19 period and the spread of hypervirulent clonal lineages, including M1UK (emm1 genotype), highlight the need for molecular genetic surveillance. Aim. To characterize the clonal structure, virulome and resistome of S. pyogenes strains isolated from hospitalized children and to assess their phenotypic antimicrobial susceptibility. Materials and methods. A total of 67 S. pyogenes strains isolated in 2023–2024 from hospitalized patients aged 0–17 years were studied. Identification was performed by MALDI-TOF mass spectrometry. Antimicrobial susceptibility testing was carried out by serial dilution methods. Whole-genome sequencing, genome assembly were performed. Bioinformatic analysis included emm typing, multilocus sequence typing, detection of virulence and antimicrobial resistance genes, and phylogenetic analysis. Results. Fourteen emm types and 19 sequence types were identified. The predominant clonal lineages were emm6/ST382 (16.4%), emm2/ST55 (14.9%), emm3/ST15 and emm75/ST49 (10.4% each). A strong association between emm and sequence types was observed (p 0.001; Cramer's V = 1.0). One strain of the M1UK lineage was identified among emm1/ST28 isolates. The virulence genes sagA, slo, mf/spd and speB were detected in all strains, while hylP was found in 86.6%. Among superantigen genes, speG (89.6%) and speC (68.7%) were most frequent. All strains were susceptible to β-lactams, clindamycin, linezolid, vancomycin. Resistance to erythromycin and tetracycline was detected in 4.5% and 14.9% of strains, respectively, and was predominantly associated with the mef(A)/msr(D) and tetM genes. Conclusion. S. pyogenes strains isolated from hospitalized children are characterized by genetic heterogeneity, a pronounced clonal structure, and genotype-specific distribution of superantigen genes. The results confirm the importance of whole-genome sequencing for monitoring the clonal structure, virulome and resistome of S. pyogenes within molecular epidemiological surveillance of GAS infections.
- Open Access
- 3 August 2026
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 25 (3) , 12-27
Epidemiological Characteristics of Acute Rheumatic Fever and Chronic Rheumatic Heart Disease in the Russian Federation and Moscow, 2012–2024
Relevance. Acute rheumatic fever (ARF) and chronic rheumatic heart disease (CRHD) remain important medical and social problems despite a declining prevalence in most developed countries. These conditions are late complications of group A streptococcal infection and are associated with chronic valvular heart disease, disability, and premature mortality. Current evidence indicates persistent regional disparities in disease distribution and possible underestimation of the true disease burden. Aim . To assess long-term trends in the incidence, prevalence, and mortality of ARF and CRHD in the Russian Federation and Moscow during 2012–2024 and to evaluate age-specific and territorial characteristics of disease distribution. Materials and Methods . A retrospective descriptive epidemiological study was conducted. Data were obtained from Federal Statistical Reporting Forms No. 12 and No. 14. Analyses were performed for the total population and for the following age groups: children aged 0–14 years, adolescents aged 15–17 years, adults aged ≥ 18 years, working-age population, and older-than-working-age population. Incidence, prevalence, and mortality rates per 100,000 population, average long-term rates (ALR), average annual growth rates (AAGR), and trend significance coefficients (t) were calculated. Time-series analysis was performed using the least-squares method with trend-line construction. Results. A total of 24,815 cases of acute rheumatic fever (ARF) and 110,255 newly diagnosed cases of chronic rheumatic heart disease (CRHD) were registered in the Russian Federation between 2012 and 2024. A statistically significant decline in the main epidemiological indicators was observed. The incidence of ARF decreased 4.3-fold, from 1.76 to 0.41 per 100,000 population (AAGR = -9.6 %; p < 0.001). The incidence of CRHD decreased 1.8-fold, from 7.31 to 4.09 per 100,000 population (AAGR = -6.2 %; p < 0.001), while the prevalence of CRHD decreased 2.0-fold, from 130.88 to 66.06 per 100,000 population (AAGR = -5.8 %; p < 0.001). Mortality from ARF decreased 9.7-fold, from 0.03 to 0.003 per 100,000 population, whereas mortality from CRHD decreased 1.8-fold, from 1.09 to 0.60 per 100,000 population. The highest ARF incidence (ALR = 5.06 per 100,000 population), CRHD incidence (ALR = 13.67 per 100,000 population), and CRHD prevalence (ALR = 194.68 per 100,000 population) were observed in the North Caucasian Federal District. The highest ARF incidence was recorded among adolescents aged 15–17 years (ALR = 3.62 per 100,000 population), whereas CRHD predominantly affected individuals older than working age, with average long-term incidence and prevalence rates of 8.27 and 210.53 per 100,000 population, respectively. In Moscow, the main epidemiological indicators of ARF and CRHD were lower than the national averages and also demonstrated statistically significant declines over the study period. Conclusion . A decrease in the incidence, prevalence, and mortality associated with ARF and CRHD was observed in the Russian Federation and Moscow during 2012–2024. However, pronounced territorial disparities and age-related differences in disease distribution persist. These findings highlight the need for further improvement of epidemiological surveillance, prevention of group A streptococcal infection and its complications, and early detection of post-streptococcal diseases.
- 3 August 2026
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 25 (3) , 12-27
Open AccessEpidemiological Characteristics of Acute Rheumatic Fever and Chronic Rheumatic Heart Disease in the Russian Federation and Moscow, 2012–2024
Relevance. Acute rheumatic fever (ARF) and chronic rheumatic heart disease (CRHD) remain important medical and social problems despite a declining prevalence in most developed countries. These conditions are late complications of group A streptococcal infection and are associated with chronic valvular heart disease, disability, and premature mortality. Current evidence indicates persistent regional disparities in disease distribution and possible underestimation of the true disease burden. Aim . To assess long-term trends in the incidence, prevalence, and mortality of ARF and CRHD in the Russian Federation and Moscow during 2012–2024 and to evaluate age-specific and territorial characteristics of disease distribution. Materials and Methods . A retrospective descriptive epidemiological study was conducted. Data were obtained from Federal Statistical Reporting Forms No. 12 and No. 14. Analyses were performed for the total population and for the following age groups: children aged 0–14 years, adolescents aged 15–17 years, adults aged ≥ 18 years, working-age population, and older-than-working-age population. Incidence, prevalence, and mortality rates per 100,000 population, average long-term rates (ALR), average annual growth rates (AAGR), and trend significance coefficients (t) were calculated. Time-series analysis was performed using the least-squares method with trend-line construction. Results. A total of 24,815 cases of acute rheumatic fever (ARF) and 110,255 newly diagnosed cases of chronic rheumatic heart disease (CRHD) were registered in the Russian Federation between 2012 and 2024. A statistically significant decline in the main epidemiological indicators was observed. The incidence of ARF decreased 4.3-fold, from 1.76 to 0.41 per 100,000 population (AAGR = -9.6 %; p < 0.001). The incidence of CRHD decreased 1.8-fold, from 7.31 to 4.09 per 100,000 population (AAGR = -6.2 %; p < 0.001), while the prevalence of CRHD decreased 2.0-fold, from 130.88 to 66.06 per 100,000 population (AAGR = -5.8 %; p < 0.001). Mortality from ARF decreased 9.7-fold, from 0.03 to 0.003 per 100,000 population, whereas mortality from CRHD decreased 1.8-fold, from 1.09 to 0.60 per 100,000 population. The highest ARF incidence (ALR = 5.06 per 100,000 population), CRHD incidence (ALR = 13.67 per 100,000 population), and CRHD prevalence (ALR = 194.68 per 100,000 population) were observed in the North Caucasian Federal District. The highest ARF incidence was recorded among adolescents aged 15–17 years (ALR = 3.62 per 100,000 population), whereas CRHD predominantly affected individuals older than working age, with average long-term incidence and prevalence rates of 8.27 and 210.53 per 100,000 population, respectively. In Moscow, the main epidemiological indicators of ARF and CRHD were lower than the national averages and also demonstrated statistically significant declines over the study period. Conclusion . A decrease in the incidence, prevalence, and mortality associated with ARF and CRHD was observed in the Russian Federation and Moscow during 2012–2024. However, pronounced territorial disparities and age-related differences in disease distribution persist. These findings highlight the need for further improvement of epidemiological surveillance, prevention of group A streptococcal infection and its complications, and early detection of post-streptococcal diseases.
- Open Access
- 3 May 2025
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 24 (2) , 14-23
Soft Tissue Infections of Streptococcal Etiology in the Purulent-Surgical Department of a Multidisciplinary Hospital
Purulent diseases of skin and soft tissues occupy the leading place among surgical infections in terms of frequency of occurrence and possible complications. The most significant etiological agents in surgical infections of soft tissues are group A streptococci (SGA), however, there are known cases of severe invasive infections caused by group B, C, G streptococci and pneumococci.Aim. To estimate the frequency and identify the features of soft tissue streptococcal infection in patients of the purulent-surgical department of a multidisciplinary hospital in Moscow.Materials and Methods. We conducted an epidemiological observational descriptive continuous retrospective study based on the analysis of data from case histories of purulent surgery patients with isolation of Streptococcus monocultures obtained from the unified medical information and analytical system (EMIAS) of a multidisciplinary hospital in Moscow for 2020–2022. Establishment of a case of invasive infection was based on the criteria proposed by the US Centers for Disease Control and Prevention (CDC), according to which a case of invasive infection is defined by the isolation of the pathogen from the sterile in normal conditions environment of the organism and laboratory confirmation of infection with clinical signs of invasive disease. Statistical processing and analysis of the study results were performed using Microsoft Excel 2010 and IBM SPSS Statistics 22.Results. During the study period, 235 cases of skin and soft tissue infections with isolation of Streptococcus monocultures were detected in the department of purulent surgery of a multidisciplinary hospital. The most frequent diagnoses were abscesses – 109 (37,59%), phlegmons – 61 (21,03%), infected wounds – 30 (10,34%), purulent destructive arthritis – 12 (4,14%). The comorbidities identified were hypertension (HD) 21.45%, diabetes mellitus (DM) 19.8%, coronary heart disease (CHD) 12.54%, and hepatitis 4.97%. The age median of all patients was 47 (IQR=20) years. On average, patients spent 9 days in hospital. In 9.79% of cases, the treatment of patients was rather long (>21 days). Among the monocultures of streptococci isolated from patients, S. pyogenes (40.78%), S. agalactiae (22.75%), S. anginosus (13.33%) and S. constellatus (6.27%) were predominant. A total of 32 (13.62%) cases of invasive soft tissue infection were identified during the study period, of which 16 (50.0%) were associated with S. agalactiae monocultures, 9 (28.13%) with S. pyogenes, and the remaining 7 (21.88%) with other streptococcal species. Male patients (87.5%) predominated in the sex and age structure. During the analysed period, mortality in the invasive form of infection was 6.25%. According to the ROC-analysis, the development of the invasive form of infection was predicted in patients aged 52 years and older. The comorbidities most closely associated with the invasive form of infection were diabetes mellitus DM (OR = 4.2), GB (OR = 2.7), CHD (OR = 4.8) and gastrointestinal inflammatory disease (OR = 14.3).Conclusion. The study demonstrated a wide prevalence of soft tissue streptococcal infection in the department of purulent surgery of a multidisciplinary hospital with the predominance of S. pyogenes, S. agalactiae, S. anginosus and S. constellatus in the etiological structure and showed the possibility of developing invasive forms of the disease associated not only with group A streptococci, but also with other species of streptococci.
- 3 May 2025
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 24 (2) , 14-23
Open AccessSoft Tissue Infections of Streptococcal Etiology in the Purulent-Surgical Department of a Multidisciplinary Hospital
Purulent diseases of skin and soft tissues occupy the leading place among surgical infections in terms of frequency of occurrence and possible complications. The most significant etiological agents in surgical infections of soft tissues are group A streptococci (SGA), however, there are known cases of severe invasive infections caused by group B, C, G streptococci and pneumococci.Aim. To estimate the frequency and identify the features of soft tissue streptococcal infection in patients of the purulent-surgical department of a multidisciplinary hospital in Moscow.Materials and Methods. We conducted an epidemiological observational descriptive continuous retrospective study based on the analysis of data from case histories of purulent surgery patients with isolation of Streptococcus monocultures obtained from the unified medical information and analytical system (EMIAS) of a multidisciplinary hospital in Moscow for 2020–2022. Establishment of a case of invasive infection was based on the criteria proposed by the US Centers for Disease Control and Prevention (CDC), according to which a case of invasive infection is defined by the isolation of the pathogen from the sterile in normal conditions environment of the organism and laboratory confirmation of infection with clinical signs of invasive disease. Statistical processing and analysis of the study results were performed using Microsoft Excel 2010 and IBM SPSS Statistics 22.Results. During the study period, 235 cases of skin and soft tissue infections with isolation of Streptococcus monocultures were detected in the department of purulent surgery of a multidisciplinary hospital. The most frequent diagnoses were abscesses – 109 (37,59%), phlegmons – 61 (21,03%), infected wounds – 30 (10,34%), purulent destructive arthritis – 12 (4,14%). The comorbidities identified were hypertension (HD) 21.45%, diabetes mellitus (DM) 19.8%, coronary heart disease (CHD) 12.54%, and hepatitis 4.97%. The age median of all patients was 47 (IQR=20) years. On average, patients spent 9 days in hospital. In 9.79% of cases, the treatment of patients was rather long (>21 days). Among the monocultures of streptococci isolated from patients, S. pyogenes (40.78%), S. agalactiae (22.75%), S. anginosus (13.33%) and S. constellatus (6.27%) were predominant. A total of 32 (13.62%) cases of invasive soft tissue infection were identified during the study period, of which 16 (50.0%) were associated with S. agalactiae monocultures, 9 (28.13%) with S. pyogenes, and the remaining 7 (21.88%) with other streptococcal species. Male patients (87.5%) predominated in the sex and age structure. During the analysed period, mortality in the invasive form of infection was 6.25%. According to the ROC-analysis, the development of the invasive form of infection was predicted in patients aged 52 years and older. The comorbidities most closely associated with the invasive form of infection were diabetes mellitus DM (OR = 4.2), GB (OR = 2.7), CHD (OR = 4.8) and gastrointestinal inflammatory disease (OR = 14.3).Conclusion. The study demonstrated a wide prevalence of soft tissue streptococcal infection in the department of purulent surgery of a multidisciplinary hospital with the predominance of S. pyogenes, S. agalactiae, S. anginosus and S. constellatus in the etiological structure and showed the possibility of developing invasive forms of the disease associated not only with group A streptococci, but also with other species of streptococci.
- Open Access
- 8 March 2025
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 24 (1) , 4-9
Eepidemiological Interregional Multicenter Study of Healthcare-Associated Infections in the Intensive Care Units. First Results
The intensive development of medical technologies is accompanied by equally rapid changes in the epidemic process of healthcare-associated infections (HAIs). According to experts, in order to increase the sensitivity of the surveillance system, official registration should be supplemented by multicenter targeted studies.Aim. To determine the prevalence and incidence of HAIs in the intensive care units (ICUs) of the Russian Federation, the dominant pathogens and their antibiotic resistance.Materials and Methods. A one-day epidemiological interregional multicenter cross-section survey of HAIs in the ICUs of the Russian Federation (EMMI) was carried out. 54 ICUs from 50 medical organizations in 27 subjects of the Russian Federation (25 specialized and 25 general hospitals) of all federal districts voluntarily participated in the study.Results. The prevalence of HAI in the intensive care unit (Ward-Specific Point Prevalence) was 19.88% [13.94–25.5]. The Incidence Density of HAI was 19.72 [15.5–25.1] cases and 28.52 [23.3–34.8] episodes per 1000 patient-days (in adults – 22.52 [17.1–29.6] cases and 32.88 [26.2–41.2] episodes of HAI per 1000 patient-days; in children – 13.54 [8.3–23.1] cases and 19.51 [12.6–29.8] episodes per 1000 patient-days; in children under 1 year – 11.44 [5.9–21.2] cases and 17.16 [10.2–28.4] episodes per 1000 patient-days). The Device-specific Incidence Density of catheter-associated bloodstream infections (CLABSI) was 7.12 [6.39–7.81] per 1000 catheterization days, catheter-associated urinary tract infections (CAUTI) – 10.99 [9.99-11.99] per 1000 catheterization days, lower respiratory tract infections – 14.56 [11.0–19.3] per 1000 patient-days and 27.33 [25.77–28.89] per 1000 days of mechanical ventilation (VAP). Three microorganisms were in the lead: Klebsiella pneumoniae (33/35.48%), Acinetobacter baumannii (16/17.20%) and Pseudomonas aeruginosa (12/12.90%). In the group of ventilator-associated pneumonia, Klebsiella pneumoniae caused 47.82% of all cases. Multidrug resistance was demonstrated by 75% of Klebsiella pneumoniae strains.Conclusion. A multicenter One-day point-prevalence survey allowed to clarify the prevalence and incidence density of HAIs in the ICU, and also revealed the dominance of multidrug-resistant Klebsiella pneumoniae in all regions as a causative agent of various forms of HAIs in the ICU. A high level of VAP was revealed, which requires additional research in order to adjust the preventive measures taken into account the characteristics of Klebsiella pneumoniae.
- 8 March 2025
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 24 (1) , 4-9
Open AccessEepidemiological Interregional Multicenter Study of Healthcare-Associated Infections in the Intensive Care Units. First Results
The intensive development of medical technologies is accompanied by equally rapid changes in the epidemic process of healthcare-associated infections (HAIs). According to experts, in order to increase the sensitivity of the surveillance system, official registration should be supplemented by multicenter targeted studies.Aim. To determine the prevalence and incidence of HAIs in the intensive care units (ICUs) of the Russian Federation, the dominant pathogens and their antibiotic resistance.Materials and Methods. A one-day epidemiological interregional multicenter cross-section survey of HAIs in the ICUs of the Russian Federation (EMMI) was carried out. 54 ICUs from 50 medical organizations in 27 subjects of the Russian Federation (25 specialized and 25 general hospitals) of all federal districts voluntarily participated in the study.Results. The prevalence of HAI in the intensive care unit (Ward-Specific Point Prevalence) was 19.88% [13.94–25.5]. The Incidence Density of HAI was 19.72 [15.5–25.1] cases and 28.52 [23.3–34.8] episodes per 1000 patient-days (in adults – 22.52 [17.1–29.6] cases and 32.88 [26.2–41.2] episodes of HAI per 1000 patient-days; in children – 13.54 [8.3–23.1] cases and 19.51 [12.6–29.8] episodes per 1000 patient-days; in children under 1 year – 11.44 [5.9–21.2] cases and 17.16 [10.2–28.4] episodes per 1000 patient-days). The Device-specific Incidence Density of catheter-associated bloodstream infections (CLABSI) was 7.12 [6.39–7.81] per 1000 catheterization days, catheter-associated urinary tract infections (CAUTI) – 10.99 [9.99-11.99] per 1000 catheterization days, lower respiratory tract infections – 14.56 [11.0–19.3] per 1000 patient-days and 27.33 [25.77–28.89] per 1000 days of mechanical ventilation (VAP). Three microorganisms were in the lead: Klebsiella pneumoniae (33/35.48%), Acinetobacter baumannii (16/17.20%) and Pseudomonas aeruginosa (12/12.90%). In the group of ventilator-associated pneumonia, Klebsiella pneumoniae caused 47.82% of all cases. Multidrug resistance was demonstrated by 75% of Klebsiella pneumoniae strains.Conclusion. A multicenter One-day point-prevalence survey allowed to clarify the prevalence and incidence density of HAIs in the ICU, and also revealed the dominance of multidrug-resistant Klebsiella pneumoniae in all regions as a causative agent of various forms of HAIs in the ICU. A high level of VAP was revealed, which requires additional research in order to adjust the preventive measures taken into account the characteristics of Klebsiella pneumoniae.
- 25 August 2024
- Published by ECO-Vector LLC in Russian Medicine
Clinical manifestations of scarlet fever in children in the megalopolis at the present stage.
BACKGROUND: according to the literature, an increase in severe forms of scarlet fever among children was noted in a number of foreign countries in 2022-2023. AIMS: to identify the current clinical features of scarlet fever in children in a large metropolis of Russia. MATERIALS AND METHODS: an observational descriptive retrospective continuous study of the clinical features of the course of scarlet fever in children was conducted according to 295 case histories of patients diagnosed with Scarlet fever from 2020 to 2022 on the basis of the GBUZ "DGKB named after Z.A. Bashlyaeva DZM", GBUZ "DGKB No. 9 named after G.N. Speransky DZM" in Moscow. The statistical processing of the material uses traditional methods for calculating extensive and intensive indicators (p1 and p2), errors of extensive indicators (m1 and m2) and standard deviations (rmax↔rmip), taking into account the confidence interval (t) and confidence probability (P=95%), a method for comparing indicators using a well-known formula, where at t ≥ 2.0 P ≥ 95% p ≤ 0.05, the definition of standard deviations, taking into account the confidence interval (t) and the confidence probability P = 95%. The comparison of percentages in the analysis of four-field conjugacy tables was performed using the exact Fisher criterion. The differences were considered statistically significant at p 0.05. RESULTS: as a result of the study, it was revealed that the abolition of strict anti-epidemic restrictions on COVID-19 in 2022 led not only to an increase in the incidence of scarlet fever among children from 0 to 18 years of age by 3.6 times in 2022 compared with 2021, but, as a result, to an increase in hospitalization of children in hospitals in Moscow. Thus, the number of hospitalized children with scarlet fever in 2022 increased by 18.0 times compared to 2020. The majority of those hospitalized (83.4%) were children from organized groups, including those aged 3 to 7 years (52.9%) and from 7 to 14 years (39.3%), with an average severity of the disease (93.6%). It was noted that that among the examined children, 53 children (18%) had a history of COVID-19, and among this group of children, one in five children had severe scarlet fever, while among children who did not have a history of COVID-19, these were significantly (p 0.001) 8.4 times less (respectively, 20.7% versus 2.5%). It was revealed that every 8-9 patients (12.2%) had various complications, mainly of a septic nature and those that arose in the first week of the disease, including otitis media, sinusitis, community-acquired pneumonia, parathonsillar and lateral pharyngeal abscesses and toxic shock syndrome. In the second week and later, complications of an infectious and allergic nature were reported, including tubulointerstitial nephritis, acute renal injury, post-infectious cardiomyopathy, acute post-streptococcal glomerulonephritis, toxic allergic vasculitis, post-streptococcal arthritis. Beta-lactam antibiotics remain the etiotropic drugs of choice. Antibiotics of the cephalosporin 53.6% and penicillin 46.4% series were used to treat scarlet fever. CONCLUSIONS: in modern conditions of the megalopolis, scarlet fever occurs with a typical clinical picture. The majority of those hospitalized were children of preschool and school age, only 12.2% of children were diagnosed with various complications of scarlet fever and the vast majority of children (93.6%) had a moderate severity of scarlet fever. It was noted that against the background of an increase in the number of hospitalized patients, the number of patients with severe scarlet fever decreases, while the incidence of complications in patients does not change (12.3% - 12.8%). It was shown that among patients who had suffered from COVID-19, scarlet fever was 8.3 times more likely to occur in severe form compared with children who had no history of COVID-19 disease (respectively, 20.7% vs. 2.5, p 0.0001).
- 25 August 2024
- Published by ECO-Vector LLC in Russian Medicine
Clinical manifestations of scarlet fever in children in the megalopolis at the present stage.
BACKGROUND: according to the literature, an increase in severe forms of scarlet fever among children was noted in a number of foreign countries in 2022-2023. AIMS: to identify the current clinical features of scarlet fever in children in a large metropolis of Russia. MATERIALS AND METHODS: an observational descriptive retrospective continuous study of the clinical features of the course of scarlet fever in children was conducted according to 295 case histories of patients diagnosed with Scarlet fever from 2020 to 2022 on the basis of the GBUZ "DGKB named after Z.A. Bashlyaeva DZM", GBUZ "DGKB No. 9 named after G.N. Speransky DZM" in Moscow. The statistical processing of the material uses traditional methods for calculating extensive and intensive indicators (p1 and p2), errors of extensive indicators (m1 and m2) and standard deviations (rmax↔rmip), taking into account the confidence interval (t) and confidence probability (P=95%), a method for comparing indicators using a well-known formula, where at t ≥ 2.0 P ≥ 95% p ≤ 0.05, the definition of standard deviations, taking into account the confidence interval (t) and the confidence probability P = 95%. The comparison of percentages in the analysis of four-field conjugacy tables was performed using the exact Fisher criterion. The differences were considered statistically significant at p 0.05. RESULTS: as a result of the study, it was revealed that the abolition of strict anti-epidemic restrictions on COVID-19 in 2022 led not only to an increase in the incidence of scarlet fever among children from 0 to 18 years of age by 3.6 times in 2022 compared with 2021, but, as a result, to an increase in hospitalization of children in hospitals in Moscow. Thus, the number of hospitalized children with scarlet fever in 2022 increased by 18.0 times compared to 2020. The majority of those hospitalized (83.4%) were children from organized groups, including those aged 3 to 7 years (52.9%) and from 7 to 14 years (39.3%), with an average severity of the disease (93.6%). It was noted that that among the examined children, 53 children (18%) had a history of COVID-19, and among this group of children, one in five children had severe scarlet fever, while among children who did not have a history of COVID-19, these were significantly (p 0.001) 8.4 times less (respectively, 20.7% versus 2.5%). It was revealed that every 8-9 patients (12.2%) had various complications, mainly of a septic nature and those that arose in the first week of the disease, including otitis media, sinusitis, community-acquired pneumonia, parathonsillar and lateral pharyngeal abscesses and toxic shock syndrome. In the second week and later, complications of an infectious and allergic nature were reported, including tubulointerstitial nephritis, acute renal injury, post-infectious cardiomyopathy, acute post-streptococcal glomerulonephritis, toxic allergic vasculitis, post-streptococcal arthritis. Beta-lactam antibiotics remain the etiotropic drugs of choice. Antibiotics of the cephalosporin 53.6% and penicillin 46.4% series were used to treat scarlet fever. CONCLUSIONS: in modern conditions of the megalopolis, scarlet fever occurs with a typical clinical picture. The majority of those hospitalized were children of preschool and school age, only 12.2% of children were diagnosed with various complications of scarlet fever and the vast majority of children (93.6%) had a moderate severity of scarlet fever. It was noted that against the background of an increase in the number of hospitalized patients, the number of patients with severe scarlet fever decreases, while the incidence of complications in patients does not change (12.3% - 12.8%). It was shown that among patients who had suffered from COVID-19, scarlet fever was 8.3 times more likely to occur in severe form compared with children who had no history of COVID-19 disease (respectively, 20.7% vs. 2.5, p 0.0001).
- Open Access
- 1 July 2023
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 22 (3) , 14-25
Clinical and Epidemiological Characteristics of Scarlet Fever in Russia
Relevance. In recent decades, large outbreaks of scarlet fever have been reported in European and Asian countries. Severe forms of the infection have become more frequent and the number of complications has also increased.Aim. To assess the incidence of scarlet fever in the Russian Federation using the official statistical sources, to identify the clinical features of scarlet fever among adults.Materials and methods. Analysis of the level and dynamics of the long-term incidence of scarlet fever in the entire population and among different age groups in Russia from 1890 to 2021 was performed based on the data of annual statistical forms. A clinical and epidemiological descriptive retrospective census study was conducted using data from the case histories of patients diagnosed with “scarlet fever” in The Infectious Disease Clinical Hospital No. 2 Moscow Healthcare Department from 2010 to 2022.Results. Three major cycles (40-50 years) can be distinguished in the long term with regard to incidence. In 1986, the rise in incidence was noted after 30 years since the previous one and it was less intensive. In the first cycle, rates increased gradually over almost 10 years beginning from 1891. In subsequent years, the incidence remained high (220-280 per 100,000), decreasing markedly to 50-60 per 100,000 population only by 1917-1918. The second cycle, from 1918 to 1942, was characterized by increasing rates (up to 462 per 100,000 population). In the third cycle (1946 - 1981), incidence rate reached a peak by 1955 (531.8 per 100,000 population), and started to gradually decrease afterwards. There were cycles lasting 3–6 years in in this period The fourth cycle (1982-1991) was not so large. In recent years (2007–2021), the incidence decreased 7.3 times (from 45.4 to 6.2 per 100 thousand). The average incidence rate during this period was 29.8 per 100 thousand. In 2022, the incidence of streptococcal infection increased 2.8 times (including scarlet fever – 3 times). The incidence increases were observed in the group 0-14 years and 14 and older (from 298,2 to 34,1 and from1,6 to 0,1respectively). As in the previous years (fourth cycle), children aged 3-6 years were the main contributors to the incidence of scarlet fever (the average incidence rate – 452,1 per 100,000). The average age of patients admitted to the hospital was 24 years (18–45 years). There was an increase in the average age of patients since 2017. During the study period, the number of hospitalized adults with scarlet fever decreased by half. In most cases (98.56%) the patients had a moderate condition at admission and only 3 had a severe condition (1.44%). The most common comorbid diagnoses were ENT-organs infections (9%), urinary tract infections (3.35%) and Wolf-Parkinson-White syndrome (2.87%). Scarlet fever had a complicated course of infection in 19 patients (9.09%). In the treatment were used cephalosporin (52.63%) and penicillin (41.63%).Conclusions. This study demonstrated a stable downward trend in the incidence of scarlet fever in the population of the Russian Federation in recent years until 2021. In 2022, the incidence increased 3 times (18.7 per 100 thousand). The number of hospitalizations among adults with scarlet fever and the number of patients with complications have decreased. The average age of patients by 5 years have increased. The treatment was carried out in accordance with clinical recommendations and the antibiotic resistance of the pathogen.
- 1 July 2023
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 22 (3) , 14-25
Open AccessClinical and Epidemiological Characteristics of Scarlet Fever in Russia
Relevance. In recent decades, large outbreaks of scarlet fever have been reported in European and Asian countries. Severe forms of the infection have become more frequent and the number of complications has also increased.Aim. To assess the incidence of scarlet fever in the Russian Federation using the official statistical sources, to identify the clinical features of scarlet fever among adults.Materials and methods. Analysis of the level and dynamics of the long-term incidence of scarlet fever in the entire population and among different age groups in Russia from 1890 to 2021 was performed based on the data of annual statistical forms. A clinical and epidemiological descriptive retrospective census study was conducted using data from the case histories of patients diagnosed with “scarlet fever” in The Infectious Disease Clinical Hospital No. 2 Moscow Healthcare Department from 2010 to 2022.Results. Three major cycles (40-50 years) can be distinguished in the long term with regard to incidence. In 1986, the rise in incidence was noted after 30 years since the previous one and it was less intensive. In the first cycle, rates increased gradually over almost 10 years beginning from 1891. In subsequent years, the incidence remained high (220-280 per 100,000), decreasing markedly to 50-60 per 100,000 population only by 1917-1918. The second cycle, from 1918 to 1942, was characterized by increasing rates (up to 462 per 100,000 population). In the third cycle (1946 - 1981), incidence rate reached a peak by 1955 (531.8 per 100,000 population), and started to gradually decrease afterwards. There were cycles lasting 3–6 years in in this period The fourth cycle (1982-1991) was not so large. In recent years (2007–2021), the incidence decreased 7.3 times (from 45.4 to 6.2 per 100 thousand). The average incidence rate during this period was 29.8 per 100 thousand. In 2022, the incidence of streptococcal infection increased 2.8 times (including scarlet fever – 3 times). The incidence increases were observed in the group 0-14 years and 14 and older (from 298,2 to 34,1 and from1,6 to 0,1respectively). As in the previous years (fourth cycle), children aged 3-6 years were the main contributors to the incidence of scarlet fever (the average incidence rate – 452,1 per 100,000). The average age of patients admitted to the hospital was 24 years (18–45 years). There was an increase in the average age of patients since 2017. During the study period, the number of hospitalized adults with scarlet fever decreased by half. In most cases (98.56%) the patients had a moderate condition at admission and only 3 had a severe condition (1.44%). The most common comorbid diagnoses were ENT-organs infections (9%), urinary tract infections (3.35%) and Wolf-Parkinson-White syndrome (2.87%). Scarlet fever had a complicated course of infection in 19 patients (9.09%). In the treatment were used cephalosporin (52.63%) and penicillin (41.63%).Conclusions. This study demonstrated a stable downward trend in the incidence of scarlet fever in the population of the Russian Federation in recent years until 2021. In 2022, the incidence increased 3 times (18.7 per 100 thousand). The number of hospitalizations among adults with scarlet fever and the number of patients with complications have decreased. The average age of patients by 5 years have increased. The treatment was carried out in accordance with clinical recommendations and the antibiotic resistance of the pathogen.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 25 (1)
To the 90th anniversary of the Department of Epidemiology and Evidence-based Medicine of the Sechenov University: from history to the present
Статья посвящена 90-летнему юбилею кафедры эпидемиологии и доказательной медицины Института общественного здоровья им. Ф.Ф. Эрисмана Первого МГМУ им. И.М. Сеченова. Выделены основные этапы в развитии кафедры. Показано, что на протяжении всей истории кафедра являлась головной в определении методологии преподавания эпидемиологии, играла ведущую роль в становлении эпидемиологии как науки, ее структуры и содержания. За последние годы в работе кафедры осуществлен ряд серьезных преобразований, направленных на внедрение в образовательный процесс новых технологий и последних достижений в области преподавания эпидемиологии. Сегодня сотрудники кафедры оперируют новейшими данными доказательной медицины, преподают дисциплину, опираясь на современные стандарты. Обучение студентов, специалистов в ординатуре и научных кадров в аспирантуре проводится согласно утвержденной рабочей программе, на основе современных учебно-методических материалов и интерактивных технологий. Период пандемии новой коронавирусной инфекции способствовал стремительному развитию телекоммуникационных возможностей и онлайн-образования. Активно работают научный кружок и школа мастерства «Эпидемиолог будущего», реализуется студенческий волонтерский проект «Авангард профилактики», направленные на подготовку специалистов, владеющих современными технологиями профилактической медицины. Коллектив кафедры активно участвует в научных проектах ИОЗ им. Эрисмана, результаты научных исследований публикуются в отечественных и зарубежных изданиях.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 25 (1)
To the 90th anniversary of the Department of Epidemiology and Evidence-based Medicine of the Sechenov University: from history to the present
Статья посвящена 90-летнему юбилею кафедры эпидемиологии и доказательной медицины Института общественного здоровья им. Ф.Ф. Эрисмана Первого МГМУ им. И.М. Сеченова. Выделены основные этапы в развитии кафедры. Показано, что на протяжении всей истории кафедра являлась головной в определении методологии преподавания эпидемиологии, играла ведущую роль в становлении эпидемиологии как науки, ее структуры и содержания. За последние годы в работе кафедры осуществлен ряд серьезных преобразований, направленных на внедрение в образовательный процесс новых технологий и последних достижений в области преподавания эпидемиологии. Сегодня сотрудники кафедры оперируют новейшими данными доказательной медицины, преподают дисциплину, опираясь на современные стандарты. Обучение студентов, специалистов в ординатуре и научных кадров в аспирантуре проводится согласно утвержденной рабочей программе, на основе современных учебно-методических материалов и интерактивных технологий. Период пандемии новой коронавирусной инфекции способствовал стремительному развитию телекоммуникационных возможностей и онлайн-образования. Активно работают научный кружок и школа мастерства «Эпидемиолог будущего», реализуется студенческий волонтерский проект «Авангард профилактики», направленные на подготовку специалистов, владеющих современными технологиями профилактической медицины. Коллектив кафедры активно участвует в научных проектах ИОЗ им. Эрисмана, результаты научных исследований публикуются в отечественных и зарубежных изданиях.
- 5 October 2021
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 70 (4) , 65-72
Russian strains of group B streptococci are different in the content and organization of the PAI-A and PAI-A1 pathogenicity islands
Group B streptococci, or Streptococcus agalactiae, are the major cause of severe diseases in newborns and adults. The PAI-A and PAI-A1 pathogenicity islands containing the sspB1 and sspB1a genes, respectively, were found among group B streptococci mobile genetic elements. The presence of sspB genes correlates with urogenital tract infections. The aim of this study was to determine the frequency of group B streptococci strains with the PAI-A and PAI-A1 pathogenicity islands, circulating in Moscow, in comparison with strains from St. Petersburg. The sspB1 gene, and hence the PAI-A pathogenicity island, was not found in the genomes of strains from Moscow. The frequency of the sspB1a gene and the PAI-A1 pathogenicity island in the genomes of clinical strains was three times higher than in the genomes of colonizing strains. Thus, it can be assumed that the genes of the sspB family are more specific of group B streptococci colonizing pregnant women and newborns.
- 5 October 2021
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 70 (4) , 65-72
Russian strains of group B streptococci are different in the content and organization of the PAI-A and PAI-A1 pathogenicity islands
Group B streptococci, or Streptococcus agalactiae, are the major cause of severe diseases in newborns and adults. The PAI-A and PAI-A1 pathogenicity islands containing the sspB1 and sspB1a genes, respectively, were found among group B streptococci mobile genetic elements. The presence of sspB genes correlates with urogenital tract infections. The aim of this study was to determine the frequency of group B streptococci strains with the PAI-A and PAI-A1 pathogenicity islands, circulating in Moscow, in comparison with strains from St. Petersburg. The sspB1 gene, and hence the PAI-A pathogenicity island, was not found in the genomes of strains from Moscow. The frequency of the sspB1a gene and the PAI-A1 pathogenicity island in the genomes of clinical strains was three times higher than in the genomes of colonizing strains. Thus, it can be assumed that the genes of the sspB family are more specific of group B streptococci colonizing pregnant women and newborns.
- Open Access
- 15 April 2020
- Published by Publishing House ABV Press in The Clinician
- Vol. 14 (1-2) , 14-23
Current epidemiological aspects of streptococcal and poststreptococcal diseases in the Russian Federation
Epidemiological situation related to the spread of streptococcal infection and post-streptococcal diseases in the world remains tense in recent decades. According to the World Health Organization, more than 616 million cases of streptococcal pharyngitis occur annually in the world. Group A Streptococcus (GAS) is the most common cause of morbidity and mortality in infectious diseases and one of the main human pathogens. The prevalence of severe cases of GAS infections amounted to 18.1 million people worldwide. At the same time, in recent years outbreaks of scarlet fever have been recorded in some countries. In 2011, scarlet fever rate was 10 times higher than the average rate of the previous decade. In the past 3 years, epidemics of scarlet fever have been registered in the UK, with an increased incidence every year. Although there are significant achievements in the fight against rheumatic fever (RF), it keeps reminding of itself in the form of new outbreaks. Currently, acute rheumatic fever (ARF) is not a mass disease, but it is a serious problem associated with heart damage. In the article, we analyzed incidence and prevalence of RF, rheumatic heart disease (RHD), chronic pharyngitis, nasopharyngitis, sinusitis and rhinitis. We present the comparative characteristic among children, adolescents and adults. We also describe high epidemiological and social significance of the problem and possible increase of RF and RHD, which cause significant social and economic damage, remaining the urgent problem of public health in Russia. It was revealed that the situation with ARF and RHD in Russia remains unstable. Between 1997 and 2016, epidemiological indicators of streptococcal infection tend to increase moderately. ARF incidence significantly increases with an average growth rate (AGR) of 2.5 %, while its prevalence has the opposite tendency to decrease. AGR was –29.2 %. RFD incidence showed a significant indicators increase with AGR of +1.1 %. At the same time, the prevalence tended to decrease and STP was –2 %. The situation makes it necessary to strengthen the epidemiological control of streptococcal infection and increase the alertness of doctors regarding the new cases of ARF and RHD.
- 15 April 2020
- Published by Publishing House ABV Press in The Clinician
- Vol. 14 (1-2) , 14-23
Open AccessCurrent epidemiological aspects of streptococcal and poststreptococcal diseases in the Russian Federation
Epidemiological situation related to the spread of streptococcal infection and post-streptococcal diseases in the world remains tense in recent decades. According to the World Health Organization, more than 616 million cases of streptococcal pharyngitis occur annually in the world. Group A Streptococcus (GAS) is the most common cause of morbidity and mortality in infectious diseases and one of the main human pathogens. The prevalence of severe cases of GAS infections amounted to 18.1 million people worldwide. At the same time, in recent years outbreaks of scarlet fever have been recorded in some countries. In 2011, scarlet fever rate was 10 times higher than the average rate of the previous decade. In the past 3 years, epidemics of scarlet fever have been registered in the UK, with an increased incidence every year. Although there are significant achievements in the fight against rheumatic fever (RF), it keeps reminding of itself in the form of new outbreaks. Currently, acute rheumatic fever (ARF) is not a mass disease, but it is a serious problem associated with heart damage. In the article, we analyzed incidence and prevalence of RF, rheumatic heart disease (RHD), chronic pharyngitis, nasopharyngitis, sinusitis and rhinitis. We present the comparative characteristic among children, adolescents and adults. We also describe high epidemiological and social significance of the problem and possible increase of RF and RHD, which cause significant social and economic damage, remaining the urgent problem of public health in Russia. It was revealed that the situation with ARF and RHD in Russia remains unstable. Between 1997 and 2016, epidemiological indicators of streptococcal infection tend to increase moderately. ARF incidence significantly increases with an average growth rate (AGR) of 2.5 %, while its prevalence has the opposite tendency to decrease. AGR was –29.2 %. RFD incidence showed a significant indicators increase with AGR of +1.1 %. At the same time, the prevalence tended to decrease and STP was –2 %. The situation makes it necessary to strengthen the epidemiological control of streptococcal infection and increase the alertness of doctors regarding the new cases of ARF and RHD.